Are you ready to rethink your neovascular age-related macular degeneration (nAMD) management strategies? New agents and evolving indications are rapidly reshaping the treatment landscape for nAMD. Join Dr. Diana Do and Dr. Deepak Sambhara for a discussion of clinical trial data and real-world evidence supporting the use of second-generation anti-vascular endothelial growth factor therapies in patients with nAMD.

Visit Optimizing Second-Generation Anti-VEGF Agents for nAMD to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

This podcast is powered by Pinecast.

Retinopathy of prematurity (ROP) is a leading cause of childhood blindness worldwide. With rapidly evolving screening protocols and treatment advances, timely intervention can significantly improve outcomes. Join Dr. Emily Eton and Dr. Brittni Scruggs as they discuss ROP classification, screening, treatment, and follow-up.

Visit Precision Vision: Developing Expertise in Retinopathy of Prematurity to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

This podcast is powered by Pinecast.

The year 2025 was filled with many developments across retinal diseases, including diabetic macular edema, diabetic retinopathy, retinal vein occlusion, neovascular age-related macular degeneration, and retinopathy of prematurity. Join Dr. Scruggs and Dr. Ip for an overview of the previous year and insights into the evolving treatment landscape.

Visit Looking Back and Ahead in Retinal Diseases: 2025 in Review to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.